Ipilimumab-induced severe meningoradiculitis

J Clin Neurosci. 2019 Apr:62:246-247. doi: 10.1016/j.jocn.2018.12.009. Epub 2018 Dec 28.

Authors

Morgane Lacour¹, Lou Grangeon¹, Jasmine Flament², Anne-Bénédicte Duval-Modeste², Aline Zaréa¹, Maxime Guillaume¹, Romain Lefaucheur³

Affiliations

¹ Department of Neurology, Rouen University Hospital and University of Rouen, France.
² Department of Dermatology, Rouen University Hospital and University of Rouen, France.
³ Department of Neurology, Rouen University Hospital and University of Rouen, France. Electronic address: romain.lefaucheur@chu-rouen.fr.

PMID: 30598268
DOI: 10.1016/j.jocn.2018.12.009

No abstract available

Keywords: Adverse effect; Immune checkpoint inhibitors; Ipilimumab; Meningoradiculitis.